ilexsaponin A1: extract from the leaves of the plant
ID Source | ID |
---|---|
PubMed CID | 72163175 |
MeSH ID | M0443133 |
Synonym |
---|
ilexsaponin a1, >=95% (lc/ms-elsd) |
ilexsaponin a |
ilexsaponin a1 |
108524-93-2 |
HY-N2638 |
CS-0023051 |
AKOS037514967 |
(3s,4r,4ar,6ar,6bs,8as,11r,12r,12as,14ar,14br)-3,12-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid |
MS-31031 |
ilexsaponina |
Excerpt | Reference | Relevance |
---|---|---|
" This study aimed to identify the metabolites of ilexsaponin A1 and evaluate its in vitro inhibitory drug-drug interaction (DDI) potential by using human liver microsomes (HLM) and cytochrome P450 enzymes (CYPs)-specific probes, with all the qualitative and quantitative analysis performed by LC-MS/MS." | ( Ilexsaponin A1: In vitro metabolites identification and evaluation of inhibitory drug-drug interactions. Bao, Y; Jin, X; Kang, A; Lv, T; Miao, P; Wu, L; Zhou, Z, 2021) | 2.32 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |